Europe
Entresto, introduced in 2015, got off to a slow start but brought in $507 million in revenue last year.
This acquisition strategy is part of its two-pronged approach to growth, along with internal R&D.
Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved.
Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires.
The trial was conducted at Rigshospitalet, University of Copenhagen, Denmark, one of the world’s leading centers for the treatment of SBS and top-line results were reported in June 2017
The year is already off to a good start with mergers and acquisitions in the biopharma industry.
Sanofi has announced major restructuring, which will involve layoffs.
The deal has Sanofi paying $105 per share in cash.
The medtech titan logged a series of legal wins this week.
The survey of 51 oncologists suggests broad uptake of Imfinzi in advanced lung cancer patients who can’t be treated with surgery.
PRESS RELEASES